Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
Mission Bio Blog and Podcast go live! Get the latest news and trends on single-cell multi-omics. Subscribe
X
Scientific presentation

Precision over bulk sequencing


Koichi Takahashi, MD
Dennis Eastbur, PhD
Jerry Radich, MD

Description

Fifty percent (50%) of patients with acute myeloid leukemia (AML) relapse and develop a more virulent form of the disease. To better understand AML and the cancer hematological ecosystem, it is necessary to discern clonal architecture and the dynamics of competing clones, which provide valuable insight into therapy response. It takes three or more mutations for leukemia to form. This can occur in the same cell or within the tumor microenvironment, but how do you discern this information with bulk sequencing? Dr. Jerry Radich, of Stanford Medical Center, and Dr. Koichi Takahashi, of MD Anderson, share their research on how they identified mutations within rare subclones using single-cell analysis for precision over bulk sequencing.



VIEW


Scientific presentation
Introducing Europe to single-cell DNA sequencing
Gema Fuerte, MS
Mission Bio (2020)
Scientific presentation
Introducing Asia to single-cell DNA sequencing
Yue Wang, PhD
Mission Bio (2020)
Scientific presentation
How to detect DNA + Protein simultaneously in a single cell
Aik Ooi, PhD
Mission Bio (2020)
Scientific presentation
Agilent Technologies discusses the incorporation of targeted single-cell multi-omics to complement their product portfolio
Kevin Corcoran
Aaron Llanso
Agilent & Mission Bio (2020)